Ticker Symbol: TTNP
Titan Pharmaceuticals, Inc. (de)
$1.57 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0000910267
Company Profile
Titan Pharmaceuticals, Inc., based in South San Francisco, CA, is a development stage company developing proprietary therapeutics with its ProNeura® long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 400 Oyster Point Blvd Ste 505
Website: www.titanpharm.com
CEO: N/A
Tags:
- Health Technology
- Biotechnology
- Pharmaceuticals: Major
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.45
Change:
$0.00
(
-0.70%)
Days Range: $0.43 - $0.47
Beta: 0.06
52wk. High: $1.13
52wk. Low: $0.36
Ytd. Change -42.21%
50 Day Moving Average: $0.46
200 Day Moving Average: $0.62
Shares Outstanding: 15016295
Valuation
Market Cap: 682.9M
PE Ratio: -0.80
EPS (TTM): -0.5705
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A